Asaka M, Kudo M, Kato M, Sugiyama T, Takeda H
The Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:9-15. doi: 10.1111/j.1365-2036.1998.00007.x.
An analysis carried out in 1994 by the WHO International Agency for Research on Cancer (IARC) resulted in Helicobacter pylori being designated as a Group 1 carcinogen and thus clearly having an association with the development of gastric cancer. In the case of H. pylori, the evaluation was made solely on the basis of epidemiological results. In Japan, in 1993, only 235,000 of the 60 million people with H. pylori had gastric cancer. This represents only 0.4% of the infected population. Each individual reacts in a unique way to H. pylori infection in terms of the inflammatory response. The probability of developing cancer will be determined by environmental factors such as diet, duration of or age at acquisition of H. pylori infection, the virulence of H. pylori strains, and host factors including genetic make-up.
1994年,世界卫生组织国际癌症研究机构(IARC)进行的一项分析结果显示,幽门螺杆菌被列为1类致癌物,因此明确与胃癌的发生有关。就幽门螺杆菌而言,该评估完全基于流行病学结果。在日本,1993年,6000万幽门螺杆菌感染者中只有23.5万人患有胃癌。这仅占感染人群的0.4%。每个人对幽门螺杆菌感染的炎症反应都有独特的方式。患癌几率将由饮食、幽门螺杆菌感染的持续时间或感染时的年龄、幽门螺杆菌菌株的毒力等环境因素以及包括基因组成在内的宿主因素决定。